Viridian Therapeutics entered mark up phase Viés de alta
Viridian Therapeutics, Inc.NASDAQ
Descrição
⋅ Viridian Therapeutics has been in an accumulation phase since 2020.
Moreover, the price has recently moved above EMAs (10, 21 and 30) with price gap and significant volume increase.
I think price will continue its mark up phase in the next days.
IMPORTANT: This is not financial advice.